Science, spirituality, and ayahuasca: The problem of consciousness and spiritual ontologies in the academy

Apud, I. | Zygon | 12 February 2017

New Studies on Hallucinogenic Mushrooms: History, Diversity, and Applications in Psychiatry

Guzmán, G. | International journal of medicinal mushrooms | 1 November 2015

Lysergic Acid Diethylamide and mystical experiences

Lyvers, M. | The neuropathology of drug addictions and substance misuse | 1 October 2016

The Entheogen Reformation

Roberts, T. B. | Association for Transpersonal Psychology | 1 October 2016

The Psychedelic Policy Quagmire: Health, Law, Freedom, and Society

Van Hagen, A. G. | BJPsych Bull | 11 August 2016

Acid Brothers: Henry Beecher, Timothy Leary, and the psychedelic of the century

Moreno, J. D. | Perspectives in Biology and Medicine | 1 August 2016

From Psychiatry to Flower Power and Back Again: The Amazing Story of Lysergic Acid Diethylamide

Mucke, H. A. | ASSAY and Drug Development Technologies | 8 July 2016

Prohibited or regulated? LSD psychotherapy and the United States Food and Drug Administration

Oram, M. | History of psychiatry | 18 May 2016

On the Origin of the Genus Psilocybe and Its Potential Ritual Use in Ancient Africa and Europe

Froese, T., Guzmán, G., & Guzmán-Dávalos, L. | Economic Botany | 10 May 2016

Psychedelics and cognitive liberty: Reimagining drug policy through the prism of human rights.

Walsh, C. | International Journal of Drug Policy | 12 January

Psychedelic medicine: a re-emerging therapeutic paradigm

Yensen, R., & Johnson, M. W. | Canadian Medical Association Journal | 08 Sep 2015

LSD: a new treatment emerging from the past

Dyck, E. | CMAJ: Canadian Medical Association journal= journal de l'Association medicale canadienne | 04 Augustus 2015

Ketamine and Phencyclidine: the good, the bad and the unexpected

Lodge, D., & Mercier, M. S. | British journal of pharmacology | 15 June 2015

Psychedelic drugs should be legally reclassified so that researchers can investigate their therapeutic potential

Rucker, J. J. | BMJ | 26 May 2015

Harmine for catatonic schizophrenia. A forgotten experiment

Hostiuc, S., Buda, O., & Ion, D. A. | Schizophrenia research | 30 June 2014

IJTS Special Topic Section: Ketamine ● Ethnographic Accounts of Ketamine Explorations in Psychedelic Culture

Ring, K., Metzner, R., & Wolfson, P. E. | International Journal of Transpersonal Studies | 2014

IJTS Special Topic Section: Ketamine ● Psychedelic Experiential Pharmacology: Pioneering Clinical Explorations with Salvador Roquet

Wolfson, P. E. | International Journal of Transpersonal Studies | 2014

IJTS Special Topic Section: Ketamine ● Making Ketamine Work in the Long Run

Early, T. S. | International Journal of Transpersonal Studies | 2014

IJTS Special Topic Section: Ketamine ● Ketamine—Its History, Uses, Pharmacology, Therapeutic Practice, and an Exploration of its Potential as a Novel Treatment for Depression

Wolfson, P.E. | The International Journal of Transpersonal Studies | 2014

Research on psychedelic substances

Brandt, S. D., & Passie, T. | Drug testing and analysis | 06 Jul 2012

Revisiting Wasson’s Soma: Exploring the Effects of Preparation on the Chemistry of Amanita Muscaria

Feeney, K. | Journal of psychoactive drugs | 20 Sep 2011

Harm potential of magic mushroom use: A review

van Amsterdam, J., Opperhuizen, A., & van den Brink, W. | Regulatory toxicology and pharmacology | 01 April 2011

Start Your Own Religion: New York State’s Acid Churches

Lander, D. R. | The Journal of Alternative and Emergent Religions | February 2011

A Prehistoric Mural in Spain Depicting Neurotropic Psilocybe Mushrooms?

Akers, B. P., Ruiz, J. F., Piper, A., & Ruck, C. A. P. | Economic Botany | 17 February 2011

Rediscovering MDMA (ecstasy): the role of the American chemist Alexander T. Shulgin

Benzenhöfer, U., & Passie, T. | Addiction | 9 July 2010